ong term follow up clinical study of cultured epithelial autografts for patients with giant congenital melanocytic nevus.
Not Applicable
Recruiting
- Conditions
- Giant congenital melanocytic nevi (GCMN)
- Registration Number
- JPRN-UMIN000042002
- Lead Sponsor
- Osaka City General hospital, &Plastic & Plastic &Reconstrucitve surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)patients didn't have given written informed consent. 2)Patients who are judged to be unsuitable as a subject by the research responsibility doctors 3)Clinical photographs and medical records not fully described
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are involved in epithelial autograft integration for giant congenital melanocytic nevus long-term outcomes?
How does cultured epithelial autograft efficacy compare to surgical excision for GCMN in preventing melanoma development?
Which biomarkers correlate with successful autograft engraftment and reduced pigmentation recurrence in JPRN-UMIN000042002 GCMN patients?
What long-term adverse events are reported in GCMN patients treated with cultured epithelial autografts, and how are they managed?
Are there combination therapies with growth factors or anti-inflammatory agents enhancing autograft outcomes for GCMN in clinical studies?